FGL1 and hepatocellular carcinoma: The findings that enhanced acetylation of FGL1 at Lys 98 by SIRT2 inhibition promoted the degradation of FGL1 prompted us to examine the correlation between Lys 98 acetylation and SIRT2 protein levels in HCC.